Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2006 Dec 15;108(13):4288-90.
doi: 10.1182/blood-2006-05-024042. Epub 2006 Aug 31.

Long-term outcome of patients given transplants of mobilized blood or bone marrow: A report from the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation

Norbert Schmitz  1 , Mary Eapen, Mary M Horowitz, Mei-Jie Zhang, John P Klein, J Douglas Rizzo, Fausto R Loberiza, Alois Gratwohl, Richard E Champlin; International Bone Marrow Transplant Registry; European Group for Blood and Marrow Transplantation
Affiliations
Comparative Study

Long-term outcome of patients given transplants of mobilized blood or bone marrow: A report from the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation

Norbert Schmitz et al. Blood. .

Abstract

We previously compared outcomes after allogeneic peripheral-blood stem cell (PBSC) and bone marrow (BM) transplantation in 706 patients with leukemia. We obtained long-term follow up on 413 of 491 patients who were alive at the time of the initial report: 141 PBSC and 272 BM recipients. Chronic graft-versus-host disease (GVHD) was more frequent after PBSC compared to BM transplantation (RR 1.65, P < .001) yet relapse rates were similar in both groups. Leukemia-free survival rates were higher after PBSC than BM transplantation for patients with advanced chronic myeloid leukemia (33% versus 25%) but lower for those in first chronic phase (41% versus 61%) due to higher rates of late transplant-related mortality. Leukemia-free survival was similar after PBSC and BM transplantation for acute leukemia. These data represent the early experience with PBSC grafts. Long-term outcomes in recipients of more recent transplants are required to better evaluate the role of PBSC grafts relative to BM transplantation.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
TRM and LFS in patients with acute and chronic leukemia after BM and PBSC transplantation. (A) Cumulative incidence of TRM in patients with acute leukemia after BM and PBSC transplantation adjusted for disease status at transplantation (n, number of evaluable patients; %, the 6-year rate of TRM). (B) Cumulative incidence of TRM in patients with chronic leukemia after BM and PBSC transplantation adjusted for disease status at transplantation (n, number of evaluable patients; %, 6-year rate of TRM). (C) Probability of LFS in patients with acute leukemia after BM and PBSC transplantation adjusted for disease status at transplantation (n, number of evaluable patients; %, 6-year rate of LFS). (D) Probability of LFS in patients with chronic leukemia after BM and PBSC transplantation adjusted for disease status at transplantation (n, number of evaluable patients; %, 6-year rate of LFS).
See this image and copyright information in PMC

References

    1. Champlin RE, Schmitz N, Horowitz MM, et al. Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation. Blood. 2000;95: 3702-3709. - PubMed
    1. Powles R, Metha J, Kulkarni S, et al. Allogeneic blood and bone marrow stem-cell transplantation in haematological malignant diseases: a randomized trial. Lancet. 2000;355: 1231-1237. - PubMed
    1. Blaise D, Kuentz M, Fortainer C, et al. Randomized trial of bone marrow versus lenograstimprimed blood cell allogeneic transplantation in patients with early-stage leukemia: a report from the Societe Franciase de Greffe de Molle. J Clin Oncol. 2000;18: 537-546. - PubMed
    1. Bensinger WI, Martin PJ, Storer B, et al. Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers. N Engl J Med. 2001;344: 175-181. - PubMed
    1. Cutler C, Giri S, Jeyapalan S, Paniagua D, Viswanathan A, Antin JH. Acute and chronic graft-versus-host disease after allogeneic peripheral blood stem cell and bone marrow transplantation. J Clin Oncol. 2001;19: 3685-3691. - PubMed

Publication types

MeSH terms